Work

A novel valproic acid prodrug as an anticancer agent that enhances doxorubicin anticancer activity and protects normal cells against its toxicity in vitro and in vivo

Year: 2014

Type: article

Source: Biochemical Pharmacology

DOI: 10.1016/j.bcp.2014.01.023

Authors: Nataly Tarasenko, Suzanne M. Cutts, Don R. Phillips, Gili Berkovitch-Luria, Elinor Bardugo-Nissim, Michal Weitman, Abraham Nudelman, Ada Rephaeli

Institutions: Tel Aviv University, La Trobe University, Bar-Ilan University

Language: English

Topic: Histone Deacetylase Inhibitors Research

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Israel Cancer Research Fund

OpenAlex ID: W2020759152

FWCI: 0.902

Cites: 58

Cited by: 19

Related to: 10